On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm’s total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed 7% CER to £2.80 billion and Core EPS rose 9% CER […]
Trending
- Speaker Johnson Joins America’s Newsroom on Fox Information
- Feds Cost 15 Medical Fraudsters In Los Angeles For $2 Billion Healthcare Fraud Schemes
- The Countless Chip Struggle
- Commodity Giants Urge CFTC to Kill Kalshi’s Oil Perp Earlier than It Launches
- The Bardo of Sickness
- Birds are extra afraid of ladies than males. Scientists don’t know why
- Oscars Predictions 2027: Is ‘You Can See Every part’ the Movie That Can Take Down ‘The Odyssey’?
- Illinois Playoff Video games to Watch on the NFHS Community
Oldest New York Newspaper Brand Est. 1725